Virtu KCG Holdings’s Pfizer PFE Stock Holding History

Virtu KCG Holdings’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-127,639	Closed	-$3.91M	–	3456
2015 Q4	$3.91M	Sell	127,639 -4,111	-3%	-$129K	0.07%	191
2015 Q3	$3.93M	Buy	131,750 +55,546	+73%	+$1.78M	0.06%	191
2015 Q2	$2.42M	Buy	76,204 +32,041	+73%	+$1.04M	0.04%	373
2015 Q1	$1.46M	Sell	44,163 -15,072	-25%	-$479K	0.03%	535
2014 Q4	$1.75M	Sell	59,235 -45,743	-44%	-$1.31M	0.03%	502
2014 Q3	$2.94M	Sell	104,978 -120,367	-53%	-$3.38M	0.06%	283
2014 Q2	$6.35M	Sell	225,345 -41,528	-16%	-$1.18M	0.1%	128
2014 Q1	$8.13M	Buy	266,873 +110,459	+71%	+$3.29M	0.1%	147
2013 Q4	$4.54M	Buy	156,414 +56,073	+56%	+$1.63M	0.05%	280
2013 Q3	$2.73M	Buy	+100,341	New	+$2.73M	0.03%	440

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's PFE Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Pfizer (PFE) stake by 77% in Q2 2017, selling an estimated $1.83M and leaving 17,567 shares worth $560K. The position accounts for 0.02% of the portfolio, ranked #1044.

Virtu KCG Holdings first reported a position in PFE in Q3 2013 and has held it in 16 quarters since. The position peaked at $5.54M in Q4 2013. 2,049 funds tracked by Wall St. Rank hold PFE as of Q2 2017.

Virtu KCG Holdings held 17,567 shares of Pfizer worth $560K as of Q2 2017.
Virtu KCG Holdings sold 57,880 Pfizer shares in Q2 2017, an estimated $1.83M.
Pfizer made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #1044 holding.
Virtu KCG Holdings first reported a position in Pfizer in Q3 2013 and has held it in 16 quarters since.
Virtu KCG Holdings's Pfizer position peaked at $5.54M in Q4 2013.
2,049 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.